RSS

Servier

A strategic partnership has been formed between biotech company, ImmunoQure, and pharma company, Servier, for the development of an interferon-alpha human autoantibody. more

News

The European Commission (EC) has granted marketing authorisation for Servier’s Lonsurf for the treatment of patients with advanced metastatic colorectal cancer (mCRC) more

News

XEN-D0103 is a potent and selective oral modulator of the cardiac potassium channel Kv1.5 more